Table 2 Comparison of effects of different intervention
Variables | Sham (n = 10) | Control (n = 10) | Atorvastatin (n = 10) | PUFA (n = 10) | Combined (n = 10) |
|---|---|---|---|---|---|
TG (mmol/L) | 1.07 ± 0.09 | 1.26 ± 0.14 | 1.18 ± 0.12 | 1.20 ± 0.17 | 1.11 ± 0.08# |
TC (mmol/L) | 3.84 ± 0.15 | 4.32 ± 0.11 | 4.16 ± 0.16 | 4.18 ± 0.13 | 4.06 ± 0.06# |
LDL-C (mmol/L) | 2.02 ± 0.11 | 2.33 ± 0.20 | 2.17 ± 0.25 | 2.19 ± 0.17 | 2.10 ± 0.12# |
HDL-C (mmol/L) | 0.92 ± 0.03 | 0.91 ± 0.03 | 0.92 ± 0.04 | 0.95 ± 0.06 | 1.01 ± 0.03# |
NO (μmol/L) | 12.18 ± 1.16 | 9.02 ± 1.00 | 10.27 ± 1.14 | 10.14 ± 1.08 | 10.88 ± 1.04# |
CRP (mg/L) | 2.10 ± 0.39 | 4.68 ± 0.37 | 3.67 ± 0.42 | 3.72 ± 0.33 | 3.28 ± 0.30# |
sVCAM (μg/mL) | 3.48 ± 0.22 | 4.98 ± 0.24 | 4.46 ± 0.53 | 4.49 ± 0.27 | 4.17 ± 0.38# |
sICAM (μg/mL) | 0.40 ± 0.04 | 0.58 ± 0.05 | 0.53 ± 0.03 | 0.53 ± 0.04 | 0.49 ± 0.04# |
MDA (nmol/L) | 0.82 ± 0.06 | 1.10 ± 0.08 | 1.02 ± 0.03 | 1.03 ± 0.03 | 0.96 ± 0.05# |